BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 369,289 | $3,774,134 | 0.21% |
| Radcliffe Capital Management, L.P. | 200,049 | $2,052,503 | 0.06% |
| LMR Partners LLP | 125,000 | $1,277,500 | 0.02% |
| Q Global Advisors, LLC | 195,489 | $20 | 0.01% |
| MARSHALL WACE, LLP | 190,150 | $1,954,743 | 0.00% |
| MMCAP International Inc. SPC | 325,000 | $32,468 | 0.00% |
| PERISCOPE CAPITAL INC. | 867,072 | $37,140 | 0.00% |
| COWEN AND COMPANY, LLC | 177,845 | $17,766 | 0.00% |
| CANTOR FITZGERALD, L. P. | 250,000 | $25 | 0.00% |
| EHP Funds Inc. | 125,186 | $6 | 0.00% |